Tali Aloya

Dr. Aloya brings over 20 years of profound managerial and technological experience in the biopharmaceutical industry. Before joining Ramot, Dr. Tali Aloya served as CEO at BioRap Technologies as well as business development director at T3, Technion Tech Transfer unit. Formerly, she was the CEO and IP director at High Jump Pharma Ltd.

Prior to that, Tali functioned as CTO & IP manager at Pelixcure company, part of Radbiomed accelerator Tali also served as CTO, and IP manager for Pharmaceutical and biotech projects at Radbiomed accelerator in addition to scouting for projects from academia and hospitals. Before RAD Biomed, she was a Project manager at Neurim pharmaceuticals.

Dr. Aloya holds a Ph.D. in Biological Chemistry, from The Hebrew University of Jerusalem where she received the "Mifal-Hapais Landau" award for distinguished Ph.D. student. She completed a Post-doctoral fellowship at the Weizmann Institute of Science.